Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00217763
What this trial is testing

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Bellus Health Inc. - a GSK company 930
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Not applicableUnknownNCT02227953
What this trial is testing

A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease

Who this might be right for
Alzheimer's Disease
Samsung Medical Center 20
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)UnknownNCT03865017
What this trial is testing

A Safety and Tolerability Study of GB301

Who this might be right for
Alzheimer Disease
VTBIO Co. LTD 20
Large-scale testing (Phase 3)Study completedNCT00829374
What this trial is testing

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Ended earlyNCT01238991
What this trial is testing

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 53
Early research (Phase 1)Study completedNCT01485302
What this trial is testing

Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients

Who this might be right for
Alzheimer's Disease
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Study completedNCT01018875
What this trial is testing

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 242
Post-approval studies (Phase 4)Study completedNCT07417670
What this trial is testing

Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Carnot Laboratories 105
Not applicableUnknownNCT06008639
What this trial is testing

Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Danyang Huichuang Medical Equipment Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT03038035
What this trial is testing

The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

Who this might be right for
Alzheimer Disease
National University Hospital, Singapore 150
Testing effectiveness (Phase 2)Ended earlyNCT00916617
What this trial is testing

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

Who this might be right for
Alzheimer Disease
Pfizer 62
Large-scale testing (Phase 3)WithdrawnNCT01211782
What this trial is testing

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Who this might be right for
Alzheimer's Disease
Cerecin
Testing effectiveness (Phase 2)UnknownNCT01569516
What this trial is testing

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Changchun Huayang High-tech Co., Ltd 288
Early research (Phase 1)Study completedNCT01850238
What this trial is testing

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Early research (Phase 1)Study completedNCT05667649
What this trial is testing

Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 7
Early research (Phase 1)WithdrawnNCT03316898
What this trial is testing

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Allergan
Next Page